rs139832787
Variant summary
Our verdict is Likely pathogenic. The variant received 9 ACMG points: 9P and 0B. PVS1PP5
The NM_024079.5(ALG8):c.478+1G>A variant causes a splice donor, intron change. The variant allele was found at a frequency of 0.000206 in 1,606,784 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_024079.5 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
- ALG8-congenital disorder of glycosylationInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: PanelApp Australia, G2P, Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- polycystic liver disease 3 with or without kidney cystsInheritance: AD Classification: STRONG, LIMITED Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 9 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ALG8 | NM_024079.5 | c.478+1G>A | splice_donor_variant, intron_variant | Intron 4 of 12 | ENST00000299626.10 | NP_076984.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ALG8 | ENST00000299626.10 | c.478+1G>A | splice_donor_variant, intron_variant | Intron 4 of 12 | 1 | NM_024079.5 | ENSP00000299626.5 |
Frequencies
GnomAD3 genomes AF: 0.000473 AC: 72AN: 152148Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000167 AC: 42AN: 251080 AF XY: 0.000125 show subpopulations
GnomAD4 exome AF: 0.000178 AC: 259AN: 1454518Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 127AN XY: 724094 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000473 AC: 72AN: 152266Hom.: 0 Cov.: 32 AF XY: 0.000443 AC XY: 33AN XY: 74448 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
ALG8 congenital disorder of glycosylation Pathogenic:4
As part of Carrier Screening testing performed at First Genomix, this variant was identified in a heterozygous state in a patient who is not affected with this condition.
This sequence change affects a donor splice site in intron 4 of the ALG8 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in ALG8 are known to be pathogenic (PMID: 19862844). This variant is present in population databases (rs139832787, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with ALG8-related conditions. ClinVar contains an entry for this variant (Variation ID: 489384). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.
not provided Pathogenic:1Uncertain:2
Identified in a cohort of individuals with cardiovascular disease, but no additional clinical information was provided (PMID: 31345219); Canonical splice site variant predicted to result in a null allele in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 31345219)
PVS1
ALG8 congenital disorder of glycosylation;C4693472:Polycystic liver disease 3 with or without kidney cysts Uncertain:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at